Please login to the form below
genomes
This page shows the latest genomes news and features for those working in and with pharma, biotech and healthcare.
UK Biobank generates “largest open access resource of exome data”
Around 50, 000 de-identifed genetic profiles available for research. The efforts of a project to sequence certain parts of a genome from 50, 000 UK Biobank participants have today come ... The data is only focused on around 2% of a human’s genome,
Latest news
-
Precision BioSciences to raise $100m for off the shelf CAR-Ts
The company says the enzyme’s ability to target a single DNA break in a complex genome to achieve gene modification without random off-targeting makes these enzymes particularly attractive. ... ARCUS, and the synthetic enzyme ARC nuclease, is built
-
UK launches National Genomic Healthcare strategy
The new strategy builds on Health Secretary Matt Hancock’s ambition to sequence 5 million genomes in the UK by 2024. ... th. genome. The project helped 1 in 4 rare disease patients achieve a diagnosis for the first time.
-
Big opportunities in big data, but EMA and industry just getting started
250m genomes sequenced, but data trapped in silos. The potential of big data to transform drug development and regulation is now established in biopharma, but Europe’s regulators and industry agree ... The report gives one eye-catching example: around
-
Grey Wolf secures £10m Series A to ‘illuminate’ tumour cells
is backed up by genome-wide studies, which validate ERAP1’s role in antigen modulation in disease and potential overexpression in certain tumour types.
-
GSK and Sanofi join Finland's 500,000 genomics study
This target represents five times as many people as England’s comparable project, the 100, 000 genomes project, which is seen as one of the world’s leading genome research projects. ... England reached its 100, 000 genome sequencing milestone last
More from news
Approximately 9 fully matching, plus 141 partially matching documents found.
Latest Intelligence
-
Genomics integration: can the NHS rise to the challenge?
This time, it hopes to sequence five million genomes within the next five years. ... When the first human genome was sequenced it took 13 years and £2bn to come to completion.
-
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
Genomics. Genomics England and its 100, 000 Genomes project has helped put the UK at the forefront of genomics.
-
2019: CRISPR and therapeutic gene editing comes of age
However, instead of restoring the original sequence, CRISPR serves as a new template that can be used to change the sequence, allowing the genome to be edited practically on demand. ... Before CRISPR, the introduction of zinc-finger nucleases (ZFNs) and
-
Cutting through the noise: CRISPR
the genome, to better identify drug targets and increase the probability of success in clinic,” he adds. ... These libraries are a collection of CRISPR reagents with a series of gRNAs attached, each of which is designed to edit one specific part of the
-
Why precision medicine demands precision engagement
New data sets are growing in size and importance, in addition to the Cancer Genome Atlas, which catalogues the genetic mutations responsible for cancer and has generated multidimensional maps of genomic
More from intelligence
Approximately 1 fully matching, plus 30 partially matching documents found.
Latest appointments
-
Editas Medicine names James Mullen as chairman
He has previously served as CEO of Patheon. Genome editing company Editas Medicine has appointed James Mullen as chairman of the board of directors.
-
Editas Medicine adds to its board of directors
Jessica Hopfield will also serve on the genome editing firm's audit committee. ... Genome editing company Editas Medicine has strengthened its board of directors with the addition of Jessica Hopfield, who will also serve on the board's audit committee.
-
Former GSK CEO joins Synthego’s advisory board
I look forward to contributing to the company’s success as the business extends further into the genome engineering market.”. ... Andrew’s appointment strengthens the company’s position as a leader in genome engineering solutions.”.
-
Paul Stockdale joins Oxford BioDynamics as CFO
A spin-out from Oxford University, Oxford BioDynamics focuses on the discovery and development of epigenetic biomarkers based on regulatory genome architecture.
-
Intellia Therapeutics appoints Dr Moncef Slaoui and Dr Frank Verwiel
They will join the board of directors. Genome editing group Intellia Therapeutics has appointed Moncef Slaoui and Frank Verwiel to join its board of directors at a time when the board ... We look forward to their guidance as we continue to advance our
More from appointments
Approximately 0 fully matching, plus 14 partially matching documents found.
Latest from PMHub
-
World AIDS Day 2018: Fighting the stigma surrounding HIV
10. Tenofovir – a nucleotide reverse transcriptase inhibitor (NtRTI). 11. Acts as a nucleotide analogue that competitively inhibits reverse transcriptase, the enzyme required for replication of the viral genome.
-
Artificial Intelligence in Healthcare
However, the robots received ‘points’ for finding the resource themselves and only the highest-scoring robots were ‘mated’; their binary code ‘genome’ forming part of the next generation of robots.
-
The dark side of direct-to-consumer genetic tests
The organisation works across 153 countries. Its services range from conducting government research to providing patients and healthcare professionals with diagnostic results, offering genome studies and using genomics in forensics. ... To date it has
-
Genetic counsellors: the new healthcare influencers?
Blue Latitude Health explores the relationship between physicians and genetic counsellors, and the impact this has on turning precision medicine into a reality for oncology patients. In April 2018, Medicare &Medicaid Services announced patients
-
Mastering the precision medicine opportunity
Craig Venter, the internationally renowned scientist behind the Human Genome Project and head of Human Longevity Inc goes so far to say that data will fundamentally transform the way medicine is
More from PMHub
Approximately 2 fully matching, plus 13 partially matching documents found.
Featured jobs
-
Director – Healthcare PR
-
Salary TBC
-
Account Director, Medical Education
-
Salary TBC
- Account Director – London based Medical Communications Agency
-
Excellent Remuneration Package
- Senior / Principal Medical Writer - MedComms - Home Based / Vari...
-
Excellent Remuneration Packages
- Senior Account Director/ Associate Director- Pharma and Life Sci...
-
Competitive salary and benefits
- Project Manager - Medical Communications – South Wales
-
Excellent Remuneration Package
- Experienced / Senior Account Director - Publications - London
-
Up to £80, 000 plus great benefits
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
- Editor – Medical Education Agency – Bucks
-
Salary TBC
-
Senior Medical Writer
-
Salary TBC
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
- Project Manager - Digital Healthcare - London
-
Excellent Remuneration Package
- Freelance Medical Writer - Healthcare Advertising - London
-
Employment Type:. Type of Job:. Region:. Salary:. 250 to 330 per day
-
Senior Medical Writer
-
Competitive salary and benefits
- Senior Account Manager- Pharma and Life Scienes
-
Competitive salary and benefits
- Account Manager / Senior Account Manager - Healthcare Advertisin...
-
Excellent Remuneration
Subscribe to our email news alerts
- With Spiriva under pressure, Boehringer moves to bolster pipeline
- Genfit claims FDA breakthrough status for liver disease drug
- Mereo’s shareholders back OncoMed takeover
- Lucid Group announces the appointment of new CFO
- From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
- Q&A: Niels Lund
PMHub
emotive.
emotive. is an award-winning healthcare communications agency working with leading global and EMEA companies in life sciences including medical device...
Latest intelligence
- From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
- How pharma is progressing their commitment in patient engagement...
- Cuttsy+Cuttsy awarded CPD Platinum by the IPA
- Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
- Breaking Bad
- Six behaviours separate the good brand teams from the bad...
Quick links
Infographics
